Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Arbutus Biopharma Corp | 67,000 | reported | 23 May 2024 | tx 9+323,000 |
| HOLLIS EDEN PHARMACEUTICALS INC /DE/ | 12,209 | reported | 14 Feb 2007 | tx 6+86,000−2,250 |
| Nabriva Therapeutics AG | 10,384 | reported | 02 Aug 2022 | tx 11+230,100−12,466 |
| Nabriva Therapeutics Plc | 10,100 | reported | 23 Jun 2017 | tx 2+30,300 |
| METABASIS THERAPEUTICS INC | 10,000 | reported | 23 Jun 2009 | tx 5+53,416 |
| Cidara Therapeutics, Inc. | 0 | reported | 07 Jan 2026 | tx 25+193,225−41,250 |
| SANTARUS INC | 0 | reported | 02 Jan 2014 | tx 38+398,000−458,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 150 | 221.50 USD | |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 2,125 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 20,500 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 11,100 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 450 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 550 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 550 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 2,125 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 875 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 875 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 1,400 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 550 | — | deriv |
| 18 Jun 2025 | GRANT_AWARD | Cidara Therapeutics, Inc. | 11,100 | 0.00 USD | deriv |
| 17 Dec 2024 | GRANT_AWARD | Cidara Therapeutics, Inc. | 20,500 | 0.00 USD | deriv |
| 18 Jul 2024 | GRANT_AWARD | Cidara Therapeutics, Inc. | 2,125 | 0.00 USD | deriv |
| 23 May 2024 | GRANT_AWARD | Arbutus Biopharma Corp | 67,000 | 0.00 USD | deriv |
| 22 Jun 2023 | GRANT_AWARD | Cidara Therapeutics, Inc. | 42,500 | 0.00 USD | deriv |
| 24 May 2023 | GRANT_AWARD | Arbutus Biopharma Corp | 55,000 | 0.00 USD | deriv |
| 02 Aug 2022 | SALE | Nabriva Therapeutics AG | 11,341 | 0.19 USD | |
| 22 Jun 2022 | GRANT_AWARD | Cidara Therapeutics, Inc. | 28,000 | 0.00 USD | deriv |
| 25 May 2022 | GRANT_AWARD | Arbutus Biopharma Corp | 41,000 | 0.00 USD | deriv |
| 02 Aug 2021 | SALE | Nabriva Therapeutics AG | 1,125 | 1.20 USD | |
| 28 Jul 2021 | GRANT_AWARD | Nabriva Therapeutics AG | 17,500 | 0.00 USD | |
| 28 Jul 2021 | GRANT_AWARD | Nabriva Therapeutics AG | 35,000 | 0.00 USD | deriv |
| 23 Jun 2021 | GRANT_AWARD | Cidara Therapeutics, Inc. | 17,500 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 31 Jul 2018.